Dexcom (Nasdaq:DXCM) today announced its effort to raise awareness for diabetes technology on World Diabetes Day.
The continuous glucose monitor (CGM) maker aims to highlight the need to improve access to diabetes technologies. It follows Abbott and Insulet as companies look to recognize World Diabetes Day and National Diabetes Awareness Month.
Dexcom unveiled a first-of-its-kind global portrait gallery as part of its “#SeeDiabetes” initiative. It aims to offer a look at people living with diabetes from all walks of life. Australian model and Dexcom technology user Bambi Northwood Blyth serves as creative director. Portrait photographer Fernando Sippel photographed users from around the world.
The initiative features a number of notable Dexcom users. It includes musical artist and actor Nick Jonas, Grammy-winner Patti LaBelle, actor Victor Garber and more.
“As a Dexcom Warrior living with diabetes, it’s an honor to bring to life this unfiltered and genuine representation of what life is like for the millions of people living with diabetes globally,” said Northwood-Blyth. “In addition to the powerful imagery, each portrait is paired with a deeply personal narrative that highlights the realities of living with diabetes, and how access to technology like Dexcom CGM can lessen the burden of this disease and greatly improve your quality of life.”
More about the Dexcom #SeeDiabetes campaign
Dexcom said the initiative reinforces its commitment to broaden access to critical diabetes technology. It also aligns with the theme for World Diabetes Day for the past three years: “Access to Diabetes Care.”
The company said elevating broad awareness represents an essential part of its efforts to increase access and reimbursement for CGM. Since the company initiated its #SeeDiabetes campaign last year, the company picked up major reimbursement wins around the world. That includes the noteworthy Medicare expansion in the U.S. The company said it brought previously unavailable CGM systems to market in nearly 20 countries over the past year, too.
“Awareness efforts like #SeeDiabetes, paired with clinical evidence that demonstrates the life-changing benefits of CGM, has led to the expansion of access to CGM for millions more people over the years,” said Dexcom president and CEO Kevin Sayer. “Dexcom is committed to working with healthcare providers, private payors, governments and nonprofit organizations around the world to significantly expand access to CGM for people with all Types of diabetes.”